Spironolactone
Product Images NDC 53002-4721

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 53002-4721). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Spironolactone 01)

Chemical structure of spironolactone, showing its steroidal core with attached functional groups including a lactone ring and a thioacetate moiety.*

FDA Label Image

Figure 1 (Spironolactone 02)

A Kaplan-Meier survival curve comparing the probability over time (months) between two groups: Spironolactone (n=822) and Placebo (n=841). The graph shows higher survival probability for the Spironolactone group compared to Placebo, with a Log-rank p-value less than 0.001, indicating statistical significance.*

FDA Label Image

Figure 2 (Spironolactone 03)

A forest plot illustrating hazard ratios (HR) with 95% confidence intervals (CI) for various subgroups from a study comparing spironolactone versus placebo. Subgroups include age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes status, serum creatinine levels, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. The plot visually compares the effectiveness of spironolactone relative to placebo across these categories.*

FDA Label Image

Label Image (Lbl530024721)

SPIRONOLACTONE 25MG TABLETS packaging label from RPK Pharmaceuticals, Inc. The label indicates 30 tablets per package, with directions to take one or two tablets a day. It includes sections for patient name, clinic name, and prescription details. The label also features warnings to keep the container tightly closed and out of reach of children. The product is identified by NDC 53002-4721-30.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.